title: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
abstract: These recommendations update information concerning the vaccine and antiviral agents available for controlling influenza during the 1998-99 influenza season (superseding MMWR 1997;46[No. RR-9:1-25]). The principal changes include a) information about the influenza virus strains included in the trivalent vaccine for 1998-99, b) more detailed information about influenza-associated rates of hospitalization, and c) updated information on the possible relationship between Guillain-Barre syndrome and influenza vaccination.
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D006801:Humans; D017589:Immunization Programs; D007223:Infant; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D007251:Influenza, Human / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D008875:Middle Aged; D011129:Polyradiculoneuropathy / Q000139:chemically induced; D012299:Rimantadine / Q000009:adverse effects / Q000627:therapeutic use; D014611:Vaccination / Q000592:standards*; D015164:Vaccines, Inactivated
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated; D012299:Rimantadine; D000547:Amantadine